Arlington Heights, IL, United States of America

Jane Werling

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 80(Granted Patents)


Company Filing History:


Years Active: 2005-2021

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Jane Werling: Innovator in Drug Delivery Systems

Introduction

Jane Werling is a prominent inventor based in Arlington Heights, IL (US). She has made significant contributions to the field of drug delivery, holding a total of six patents. Her innovative work focuses on the development of surface-modified particles that enhance the efficacy of drug delivery systems.

Latest Patents

Among her latest patents, Jane has developed compositions and methods for drug delivery. One patent discloses surface-modified particles that consist of a particle core and a coating. The particle core contains an active agent, while the coating includes a surfactant, resulting in particles with an average size ranging from about 1 nm to about 2,000 nm. Another patent also addresses surface-modified particles, where the coating comprises an opsonin, further optimizing the delivery of therapeutic agents.

Career Highlights

Throughout her career, Jane has worked with notable companies such as Baxter International Inc. and Baxter Healthcare SA. Her experience in these organizations has allowed her to refine her expertise in drug delivery technologies and contribute to advancements in the field.

Collaborations

Jane has collaborated with esteemed colleagues, including James E. Kipp and Mark Joseph Doty. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Jane Werling's contributions to drug delivery systems exemplify her dedication to innovation in the medical field. Her patents and collaborations highlight her role as a leading inventor in this important area of research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…